Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 5/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16781368 | 0.81 | KMT2A (0.44) | MEN1KMT2AHTR2BALDH1A1L3MBTL1 | |
| SCHEMBL16804113 | 0.81 | KMT2A (0.44) | MEN1KMT2AHTR2BALDH1A1L3MBTL1 | |
| SCHEMBL18673134 | 0.78 | — | — | |
| SCHEMBL6033629 | 0.73 | KEAP1 (0.36) | KEAP1NFE2L2ATML3MBTL1 | |
| SCHEMBL19084383 | 0.72 | CA1 (0.36) | MEN1KMT2ANPBWR1L3MBTL1 | |
| SCHEMBL3781297 | 0.69 | KEAP1 (0.56) | KEAP1NFE2L2ATML3MBTL1 | |
| SCHEMBL22415944 | 0.67 | CHRM2 (0.47) | MEN1KMT2AALDH1A1 | |
| SCHEMBL22415869 | 0.67 | CHRM5 (0.42) | MEN1KMT2AALDH1A1 | |
| SCHEMBL22416019 | 0.67 | CHRM2 (0.47) | MEN1KMT2AALDH1A1 | |
| SCHEMBL22415855 | 0.67 | CHRM5 (0.42) | MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170192025-A1 | METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY | AMERITOX LLC (US) | 2017-07-06 | — | — | US | disclosed |
| US-20170192025-A1 | METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY | AMERITOX LLC (US) | 2017-07-06 | — | — | US | disclosed |
| US-9606132-B2 | Methods of monitoring adherence to lurasidone therapy | AMERITOX, LTD. (US) | 2017-03-28 | — | — | US | disclosed |
| US-9606132-B2 | Methods of monitoring adherence to lurasidone therapy | AMERITOX, LTD. (US) | 2017-03-28 | — | — | US | disclosed |
| US-20150168431-A1 | METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY | AMERITOX, LTD. | 2015-06-18 | — | — | US | disclosed |
| US-20150168431-A1 | METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY | AMERITOX, LTD. | 2015-06-18 | — | — | US | disclosed |